Karyopharm Therapeutics Inc. (KPTI) AI Dilution Summary
Updated Nov 3, 2026
Estimated cash was $65,105,000 as of 2026-06-30, against estimated monthly burn of $7,943,167. The funding channel is the ATM with Jefferies LLC. It is authorised to $100,000,000, and 2,994,441 shares were sold since the program began through 2026-06-30. Sales after 2026-06-30 are not yet reported.